Prescriber Survey Opportunity Due April 30: Texas Prescription Drug Monitoring Program

Published on

The annual Centers for Medicare and Medicaid Services (CMS) Drug Utilization Review Survey contains a new, required section of responses related to the Texas Prescription Drug Monitoring Program (PDMP). This year's survey is for data material from Federal Fiscal Year 2023 (Oct. 1, 2022, to Sept. 30, 2023).

CMS now requires Medicaid to report data about prescribing providers' use of PDMPs before prescribing controlled substances. Texas Medicaid obtains this information from the Texas State Board of Pharmacy but does not have access to the PDMP data. A voluntary provider survey created by HHSC will assist HHSC in gathering the required data needed to report on Texas's PDMP usage and meet federal reporting requirements.

HHSC is disseminating the CMS DUR Annual Survey–Provider PDMP Survey for prescribers across multiple platforms and will collect and analyze the responses.

HHSC requests prescribing providers to participate in the survey by April 30, 2024.